Catherine Harmer, Professor of Cognitive Neuroscience at Oxford and outgoing president of the British Association of Psychopharmacology (BAP), and Naomi Fineberg, Professor of Psychiatry at the University of Hertfordshire and incoming BAP president, discuss how BAP brings together non-clinical scientists, experimental medicine researchers, clinicians, and industry to translate discoveries into patient care.
They explore growing involvement of people with lived experience through a panel shaping council work and the summer meeting, and the need to balance professional and lived-experience perspectives. Fineberg highlights BAP’s evidence-based guidelines, aimed at improving patient outcomes via clinician uptake, and plans to strengthen dissemination through NHS engagement, accessible formats, training, and webinars. They also address support for early career researchers and pipeline challenges, strategy implementation during the presidential handover, and how global stressors and emerging digital and genetic data may reshape mental health research and precision medicine.
00:00 Meet the Presidents
00:55 What BAP Does
01:17 Bridging Lab to Clinic
02:47 Lived Experience Voices
06:08 BAP Guidelines Explained
07:03 Getting Guidance to Clinics
08:30 Supporting Early Careers
09:11 Pipeline Challenges
10:57 Handover and Strategy
12:39 Global Pressures and Hope
Find out more about the 2026 Summer Meeting of the British Association of Psychopharmacology to be held at the University of Birmingham, 19th-22nd July. https://www.bap.org.uk/summermeetinghome.php?meetingID=19
Hosted on Acast. See acast.com/privacy for more information.
